EANO–ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with leptomeningeal metastasis from solid tumours-Reference-Cited by-同舟云学术

EANO–ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with leptomeningeal metastasis from solid tumours

Published:2017-07 Issue: Volume:28 Page:iv84-iv99
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Le Rhun E.,Weller M.,Brandsma D.,Van den Bent M.,de Azambuja E.,Henriksson R.,Boulanger T.,Peters S.,Watts C.,Wick W.,Wesseling P.,Rudà R.,Preusser M.

Funder

ESMO

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/28/suppl_4/iv84/18564046/mdx221.pdf

Reference147 articles.

1. Leptomeningeal metastases: a RANO proposal for response criteria;Chamberlain;Neuro Oncol,2017

2. Breast cancer leptomeningeal metastasis—the role of multimodality treatment;Rudnicka;J Neurooncol,2007

3. Survival of breast cancer patients with meningeal carcinomatosis;Gauthier;Ann Oncol,2010

4. Leptomeningeal metastases from breast cancer: intrinsic subtypes may affect unique clinical manifestations;Lee;Breast Cancer Res Treat,2011

5. Meningeal carcinomatosis in breast cancer: prognostic factors and outcome;de Azevedo;J Neurooncol,2011

Cited by 266 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intrathecal chemotherapy for leptomeningeal disease in high-grade gliomas: a systematic review;Journal of Neuro-Oncology;2024-01-31

2. Early hint of mNGS and CNVs, an occult case of leptomeningeal metastasis with rapid cognitive decline;2024-01-30

3. Diagnostic value of cerebrospinal fluid human epididymis protein 4 for leptomeningeal metastasis in lung adenocarcinoma;Frontiers in Immunology;2024-01-18

4. Long-term response to sequential anti-HER2 therapies including trastuzumab-deruxtecan in a patient with HER2-positive metastatic breast cancer with leptomeningeal metastases: a case report and review of the literature;Frontiers in Oncology;2024-01-10

5. Therapeutic role of EGFR - Tyrosine kinase inhibitors in non-small cell lung cancer with leptomeningeal metastasis;Translational Oncology;2024-01